| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| avalglucosidase alfa | lysosomal alpha-glucosidase | NA | Clinical trial target | TTD | Hydrolysis[MeSHID:D006868] Late Onset Disorders[MeSHID:D000067562] Lysosomes[MeSHID:D008247] Glycogen storage disease type II[MeSHID:D006009] Malnutrition[MeSHID:D044342] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | phase 3 | unknown |
| avalglucosidase alfa | cation-independent mannose-6-phosphate receptor | biotech | NA | drugbank | Hydrolysis[MeSHID:D006868] Late Onset Disorders[MeSHID:D000067562] Lysosomes[MeSHID:D008247] Glycogen storage disease type II[MeSHID:D006009] Malnutrition[MeSHID:D044342] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | ligand |
| click here to return to the previous page | ||||||||